These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 23185343)

  • 1. Dopamine D1, D2, D3 receptors, vesicular monoamine transporter type-2 (VMAT2) and dopamine transporter (DAT) densities in aged human brain.
    Sun J; Xu J; Cairns NJ; Perlmutter JS; Mach RH
    PLoS One; 2012; 7(11):e49483. PubMed ID: 23185343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of dopamine D₃ receptor in the striatal regions and substantia nigra in diffuse Lewy body disease.
    Sun J; Cairns NJ; Perlmutter JS; Mach RH; Xu J
    Neuroscience; 2013 Sep; 248():112-26. PubMed ID: 23732230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coordinated expression of dopamine transporter and vesicular monoamine transporter in the primate striatum during development.
    Elsworth JD; Redmond DE; Roth RH
    Synapse; 2013 Sep; 67(9):580-5. PubMed ID: 23468413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [3H]4-(dimethylamino)-N-(4-(4-(2-methoxyphenyl)piperazin-1-yl) butyl)benzamide: a selective radioligand for dopamine D(3) receptors. II. Quantitative analysis of dopamine D(3) and D(2) receptor density ratio in the caudate-putamen.
    Xu J; Hassanzadeh B; Chu W; Tu Z; Jones LA; Luedtke RR; Perlmutter JS; Mintun MA; Mach RH
    Synapse; 2010 Jun; 64(6):449-59. PubMed ID: 20175227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential regulation of the dopamine D1, D2 and D3 receptor gene expression and changes in the phenotype of the striatal neurons in mice lacking the dopamine transporter.
    Fauchey V; Jaber M; Caron MG; Bloch B; Le Moine C
    Eur J Neurosci; 2000 Jan; 12(1):19-26. PubMed ID: 10651856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid and differential losses of in vivo dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) radioligand binding in MPTP-treated mice.
    Kilbourn MR; Kuszpit K; Sherman P
    Synapse; 2000 Mar; 35(4):250-5. PubMed ID: 10657034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of genotype effect on D1, D2 receptors and dopamine transporter binding in triple MOP-, DOP-, and KOP-opioid receptor knockout mice of three different genetic backgrounds.
    Yoo JH; Bailey A; Ansonoff M; Pintar JE; Matifas A; Kieffer BL; Kitchen I
    Synapse; 2010 Jul; 64(7):520-7. PubMed ID: 20196137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No differential regulation of dopamine transporter (DAT) and vesicular monoamine transporter 2 (VMAT2) binding in a primate model of Parkinson disease.
    Tian L; Karimi M; Loftin SK; Brown CA; Xia H; Xu J; Mach RH; Perlmutter JS
    PLoS One; 2012; 7(2):e31439. PubMed ID: 22359591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine receptors and transporters in the brain reward circuits of type 1 and 2 alcoholics measured with human whole hemisphere autoradiography.
    Tupala E; Hall H; Mantere T; Räsänen P; Särkioja T; Tiihonen J
    Neuroimage; 2003 May; 19(1):145-55. PubMed ID: 12781734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysregulation of Striatal Dopamine Receptor Binding in Suicide.
    Fitzgerald ML; Kassir SA; Underwood MD; Bakalian MJ; Mann JJ; Arango V
    Neuropsychopharmacology; 2017 Mar; 42(4):974-982. PubMed ID: 27402414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic activities in the human striatum: rostrocaudal gradients of uptake sites and of D1 and D2 but not of D3 receptor binding or dopamine.
    Piggott MA; Marshall EF; Thomas N; Lloyd S; Court JA; Jaros E; Costa D; Perry RH; Perry EK
    Neuroscience; 1999 May; 90(2):433-45. PubMed ID: 10215149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of dopamine presynaptic markers and receptors in the striatum of DJ-1 and Pink1 knockout rats.
    Sun J; Kouranova E; Cui X; Mach RH; Xu J
    Neurosci Lett; 2013 Dec; 557 Pt B(0 0):123-8. PubMed ID: 24157858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine D1 and D2 receptors influence dopamine transporter synthesis and degradation in the rat.
    Kimmel HL; Joyce AR; Carroll FI; Kuhar MJ
    J Pharmacol Exp Ther; 2001 Jul; 298(1):129-40. PubMed ID: 11408534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal deprivation-caused behavioral abnormalities in adult rats relate to a non-methylation-regulated D2 receptor levels in the nucleus accumbens.
    Zhu X; Li T; Peng S; Ma X; Chen X; Zhang X
    Behav Brain Res; 2010 Jun; 209(2):281-8. PubMed ID: 20144661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Biogenic Amine Transporters in Trace Amine-Associated Receptor 1 Regulation of Methamphetamine-Induced Neurotoxicity.
    Miner NB; Phillips TJ; Janowsky A
    J Pharmacol Exp Ther; 2019 Oct; 371(1):36-44. PubMed ID: 31320495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vesicular neurotransmitter transporters in Huntington's disease: initial observations and comparison with traditional synaptic markers.
    Suzuki M; Desmond TJ; Albin RL; Frey KA
    Synapse; 2001 Sep; 41(4):329-36. PubMed ID: 11494403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Striatal dopamine D1 and D2 receptors: widespread influences on methamphetamine-induced dopamine and serotonin neurotoxicity.
    Gross NB; Duncker PC; Marshall JF
    Synapse; 2011 Nov; 65(11):1144-55. PubMed ID: 21584865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the 5α-reductase enzyme inhibitor dutasteride in the brain of intact and parkinsonian mice.
    Litim N; Morissette M; Caruso D; Melcangi RC; Di Paolo T
    J Steroid Biochem Mol Biol; 2017 Nov; 174():242-256. PubMed ID: 28982631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presynaptic control of striatal dopamine neurotransmission in adult vesicular monoamine transporter 2 (VMAT2) mutant mice.
    Patel J; Mooslehner KA; Chan PM; Emson PC; Stamford JA
    J Neurochem; 2003 May; 85(4):898-910. PubMed ID: 12716422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signal transduction pathway activity compensates dopamine D₂/D₃ receptor density changes in Parkinson's disease: a preliminary comparative human brain receptor autoradiography study with [³H]raclopride and [³⁵S]GTPγS.
    Farkas S; Nagy K; Jia Z; Hortobágyi T; Varrone A; Halldin C; Csiba L; Gulyás B
    Brain Res; 2012 May; 1453():56-63. PubMed ID: 22480734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.